Animal Fungal Treatment Market - Growth Drivers and Challenges
Growth Drivers
- Rising Government Initiatives - By recognizing the interdependence of human, animal, and environmental health, the government is promoting a comprehensive approach to health. One of the benefits of a government program for animal health is to increase awareness and management of zoonoses, which can be transmitted from animals to humans. Furthermore, it is necessary to improve cooperation between doctors, veterinarians, environmental scientists, and Public Health Experts to promote the health and welfare of all animal species. By fostering connections between different communities and industries that drive the animal fungal treatment market, the government programme aims to generate new and improved concepts that address the underlying issues and produce long-term, sustainable solutions for animal health and well-being.
- Expansion of Pet Ownerships - Whenever the summer approaches, veterinarians warn pet owners to be alert for a possible fungus infection that may affect their animals as temperatures increase. In addition, health officials are informing pet owners of the potential for their animals to be infected with an uncommon fungal disease. Blastomycosis, a fungus, can be contracted by animals living in soil that resembles a humus. Therefore, the rivers, lakes, streams and marshes are common places where they might be exposed to it. From 1988 to 2023, approximately 66 % of US households reported that they owned at least one pet, an increase of about 18 % from the previous survey period.
Challenges
- Lack of Adequate Animal Care Infrastructure - Livestock provides a wide range of important benefits to healthy diets and survival resources. This is particularly true in developing countries, where there are limited options for nutrition-dense foods. The development of fungal treatment methods for the welfare of farm animals needs to be coordinated with the production of animal products in order to ensure that food systems are sustainable.
- Limited Availability of Fungal Treatment in Developing Countries is set to hinder animal fungal treatment market growth in the forecast period
- The High Cost of treatment is set to hinder market expansion in the projected period
Animal Fungal Treatment Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
6.9% |
|
Base Year Market Size (2025) |
USD 1.44 billion |
|
Forecast Year Market Size (2035) |
USD 2.81 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of animal fungal treatment is assessed at USD 1.53 billion.
The global animal fungal treatment market size was valued at more than USD 1.44 billion in 2025 and is expected to register a CAGR of over 6.9%, exceeding USD 2.81 billion revenue by 2035.
North America is anticipated to secure a lucrative revenue share in the animal fungal treatment market, owing to the high prevalence of fungal skin diseases in animals and the region’s strong veterinary R&D advancements.
Key players in the market include Neogen Corporation, MP AGRO CO., LTD., NIHON NOHYAKU CO., LTD., SynergyLabs, Dechra Pharmaceuticals, Vetoquinol.
